<p>Balyasny Asset Management L.P. 在第二季度将其在信诺保险集团（NYSE:CI - 免费报告）的持股比例提高了 1,057.2%，根据该公司最近向美国证券交易委员会提交的 13F 文件。该公司在季度内购买了额外的 369,775 股后，持有该健康服务提供商的 404,753 股股票。Balyasny Asset Management L.P. 在最近的报告期末持有约 0.15% 的信诺保险集团股份，价值 133,803,000 美元。</p>
<ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
<p>其他对冲基金和机构投资者最近也买卖了该公司的股票。Flaharty Asset Management LLC 在第一季度购买了信诺保险集团的新头寸，价值 28,000 美元。1248 Management LLC 在第一季度购买了信诺保险集团的新股份，价值约 29,000 美元。Solstein Capital LLC 在第二季度购买了信诺保险集团的新股份，价值约 29,000 美元。Activest Wealth Management 在第一季度将其在信诺保险集团的持股增加了 360.0%。Activest Wealth Management 现在持有 92 股该健康服务提供商的股票，价值 30,000 美元，此前在上个季度又购买了 72 股。最后，Chilton Capital Management LLC 在第二季度购买了信诺保险集团的新股份，价值约 30,000 美元。对冲基金和其他机构投资者持有该公司 86.99% 的股票。</p>
<h2>分析师评级变动</h2>
<p>几位研究分析师对该公司发布了报告。瑞银集团在 11 月 12 日的研究报告中将信诺保险集团的目标价格设定为 294.00 美元。巴克莱将信诺保险集团的目标价格从 383.00 美元下调至 300.00 美元，并在 10 月 31 日的报告中对该公司给予了 “增持” 评级。Cowen 在 12 月 5 日的研究报告中重申了对信诺保险集团股票的 “买入” 评级。摩根士丹利在 10 月 31 日的研究报告中重新发布了 “增持” 评级，并将信诺保险集团股票的目标价格设定为 355.00 美元。最后，Wolfe Research 在 10 月 15 日的报告中将信诺保险集团股票的目标价格从 345.00 美元下调至 325.00 美元，并对该股票给予了 “跑赢大盘” 的评级。一位股票研究分析师对该股票给予了强烈买入评级，十九位分析师给予了买入评级，三位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价格为 331.77 美元。</p>
<ul>
<li>尽管医疗保险优势损失，Humana 仍然获利——有什么隐情？</li>
</ul>
<p><strong>查看我们最新的 CI 股票分析</strong></p>
<h2>信诺保险集团内部活动</h2>
<p>在相关消息中，首席执行官 David Cordani 于 11 月 3 日购买了 4,134 股信诺保险集团股票，交易总额为 999,931.92 美元，平均每股价格为 241.88 美元。收购后，首席执行官直接持有该公司 157,935 股股票，价值约 38,201,317.80 美元。此次交易使其持股比例增加了 2.69%。该购买在美国证券交易委员会的备案中披露，相关文件可通过此链接获取。此外，内部人士 Brian C. Evanko 于 10 月 3 日出售了 5,368 股该股票，交易总额为 1,610,400.00 美元，平均每股价格为 300.00 美元。交易完成后，内部人士持有该公司 51,182 股股票，价值 15,354,600 美元。此次出售的披露信息可在美国证券交易委员会的备案中找到。目前，公司的内部人士持有 0.70% 的股票。</p>
<h2>信诺保险集团价格表现</h2>
<ul>
<li>MarketBeat 周回顾 – 01/06 - 01/10</li>
</ul>
<p>CI 股票在周五开盘价为 274.70 美元。该公司的流动比率为 0.76，速动比率为 0.76，债务与股本比率为 0.74。该股票的市值为 733.8 亿美元，市盈率为 12.12，市盈增长比率为 0.99，贝塔值为 0.26。该股票的 50 日简单移动平均线为 280.44 美元，200 日简单移动平均线为 294.17 美元。信诺保险集团的 12 个月低点为 239.51 美元，12 个月高点为 350.00 美元。</p>
<p>信诺保险集团（NYSE:CI - 获取免费报告）最近于 10 月 30 日公布了其财报。该健康服务提供商报告的每股收益（EPS）为 7.83 美元，超出市场共识预期的 7.64 美元，超出幅度为 0.19 美元。信诺保险集团的股本回报率为 18.80%，净利润率为 2.29%。该公司在本季度的收入为 695.7 亿美元，而分析师预期为 664.0 亿美元。在去年同期，该公司每股收益为 7.51 美元。该公司的季度收入较去年同期增长了 9.5%。信诺保险集团已将其 2025 财年的指导目标设定为 29.600- 每股收益。分析师平均预测信诺保险集团本财年将发布 29.77 美元的每股收益。</p>
<h2>信诺保险集团宣布分红</h2>
<p>该公司最近还披露了季度分红，将于 12 月 18 日支付。12 月 4 日的登记投资者将获得每股 1.51 美元的分红。这相当于每年 6.04 美元的分红，收益率为 2.2%。该分红的除息日为 12 月 4 日。信诺保险集团的分红支付比率目前为 26.64%。</p>
<h2>信诺保险集团简介</h2>
<p>（免费报告）</p>
<p>信诺保险集团及其子公司在美国提供保险及相关产品和服务。其 Evernorth 健康服务部门提供一系列协调和定点解决方案的健康服务，包括药品福利、家庭送药、特殊药房、分销以及向健康计划、雇主、政府组织和医疗服务提供者提供的护理交付和管理解决方案。</p>
<h2>精选故事</h2>
<ul>
<li>我们更看好的五只股票超过信诺保险</li>
<li>如何寻找被低估的股票</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>你能给自己最好的节日礼物是什么？好市多股票</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
<p><strong>想看看其他对 CI 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取信诺保险（NYSE:CI - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ"/></p>
<p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
<h2>你现在应该投资 1,000 美元在信诺保险吗？</h2>
<p>在考虑信诺保险之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而信诺保险并不在名单上。</p>
<p>虽然信诺保险目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>在这里查看这五只股票</p>

信诺保险

<p>Balyasny Asset Management 在第二季度将其在信诺保险的股份增加了 1,057.2%，持有 404,753 股，价值 1.338 亿美元。分析师的评级意见不一，普遍共识为 “适度买入”，平均目标价为 331.77 美元。首席执行官 David Cordani 购买了 4,134 股，而内部人士 Brian C. Evanko 卖出了 5,368 股。信诺保险的股票开盘价为 274.70 美元，市值为 733.8 亿美元，市盈率为 12.12</p>

<p>Balyasny Asset Management L.P. lifted its stake in Cigna Group (NYSE:CI - Free Report) by 1,057.2% in the second quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 404,753 shares of the health services provider's stock after purchasing an additional 369,775 shares during the quarter. Balyasny Asset Management L.P. owned about 0.15% of Cigna Group worth $133,803,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>Balyasny Asset Management L.P. 在第二季度将其在信诺保险集团（NYSE:CI - 免费报告）的持股比例提高了 1,057.2%，根据该公司最近向美国证券交易委员会提交的 13F 文件。该公司在季度内购买了额外的 369,775 股后，持有该健康服务提供商的 404,753 股股票。Balyasny Asset Management L.P. 在最近的报告期末持有约 0.15% 的信诺保险集团股份，价值 133,803,000 美元。</p>
</div><ul>
<li>UnitedHealth Group: Pariah to Pole Position to Buy the Dip Levels</li>
</ul>
<div class="lb-trans"><ul>
<li>联合健康集团：从被排斥到买入的最佳时机</li>
</ul>
</div><p>Other hedge funds and other institutional investors also recently bought and sold shares of the company. Flaharty Asset Management LLC purchased a new position in Cigna Group during the first quarter worth $28,000. 1248 Management LLC bought a new stake in shares of Cigna Group in the 1st quarter worth about $29,000. Solstein Capital LLC purchased a new position in shares of Cigna Group during the 2nd quarter worth about $29,000. Activest Wealth Management grew its holdings in Cigna Group by 360.0% during the 1st quarter. Activest Wealth Management now owns 92 shares of the health services provider's stock valued at $30,000 after purchasing an additional 72 shares during the last quarter. Finally, Chilton Capital Management LLC purchased a new stake in Cigna Group in the 2nd quarter worth about $30,000. Hedge funds and other institutional investors own 86.99% of the company's stock.</p>
<div class="lb-trans"><p>其他对冲基金和机构投资者最近也买卖了该公司的股票。Flaharty Asset Management LLC 在第一季度购买了信诺保险集团的新头寸，价值 28,000 美元。1248 Management LLC 在第一季度购买了信诺保险集团的新股份，价值约 29,000 美元。Solstein Capital LLC 在第二季度购买了信诺保险集团的新股份，价值约 29,000 美元。Activest Wealth Management 在第一季度将其在信诺保险集团的持股增加了 360.0%。Activest Wealth Management 现在持有 92 股该健康服务提供商的股票，价值 30,000 美元，此前在上个季度又购买了 72 股。最后，Chilton Capital Management LLC 在第二季度购买了信诺保险集团的新股份，价值约 30,000 美元。对冲基金和其他机构投资者持有该公司 86.99% 的股票。</p>
</div><h2>Analyst Ratings Changes</h2>
<div class="lb-trans"><h2>分析师评级变动</h2>
</div><p>Several research analysts have issued reports on the company. UBS Group set a $294.00 target price on Cigna Group in a research report on Wednesday, November 12th. Barclays dropped their price objective on Cigna Group from $383.00 to $300.00 and set an &#34;overweight&#34; rating for the company in a report on Friday, October 31st. Cowen reiterated a &#34;buy&#34; rating on shares of Cigna Group in a research note on Friday, December 5th. Morgan Stanley reissued an &#34;overweight&#34; rating and set a $355.00 target price on shares of Cigna Group in a research note on Friday, October 31st. Finally, Wolfe Research cut their price target on shares of Cigna Group from $345.00 to $325.00 and set an &#34;outperform&#34; rating on the stock in a report on Wednesday, October 15th. One equities research analyst has rated the stock with a Strong Buy rating, nineteen have assigned a Buy rating, three have assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of &#34;Moderate Buy&#34; and an average target price of $331.77.</p>
<div class="lb-trans"><p>几位研究分析师对该公司发布了报告。瑞银集团在 11 月 12 日的研究报告中将信诺保险集团的目标价格设定为 294.00 美元。巴克莱将信诺保险集团的目标价格从 383.00 美元下调至 300.00 美元，并在 10 月 31 日的报告中对该公司给予了 “增持” 评级。Cowen 在 12 月 5 日的研究报告中重申了对信诺保险集团股票的 “买入” 评级。摩根士丹利在 10 月 31 日的研究报告中重新发布了 “增持” 评级，并将信诺保险集团股票的目标价格设定为 355.00 美元。最后，Wolfe Research 在 10 月 15 日的报告中将信诺保险集团股票的目标价格从 345.00 美元下调至 325.00 美元，并对该股票给予了 “跑赢大盘” 的评级。一位股票研究分析师对该股票给予了强烈买入评级，十九位分析师给予了买入评级，三位分析师给予了持有评级，一位分析师给予了卖出评级。根据 MarketBeat 的数据，该股票的共识评级为 “适度买入”，平均目标价格为 331.77 美元。</p>
</div><ul>
<li>Humana Gains Despite Medicare Advantage Losses—What’s the Catch?</li>
</ul>
<div class="lb-trans"><ul>
<li>尽管医疗保险优势损失，Humana 仍然获利——有什么隐情？</li>
</ul>
</div><p><strong>View Our Latest Stock Analysis on CI</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 CI 股票分析</strong></p>
</div><h2>Insider Activity at Cigna Group</h2>
<div class="lb-trans"><h2>信诺保险集团内部活动</h2>
</div><p>In related news, CEO David Cordani purchased 4,134 shares of Cigna Group stock in a transaction dated Monday, November 3rd. The shares were acquired at an average price of $241.88 per share, for a total transaction of $999,931.92. Following the acquisition, the chief executive officer directly owned 157,935 shares in the company, valued at approximately $38,201,317.80. The trade was a 2.69% increase in their ownership of the stock. The purchase was disclosed in a filing with the Securities &amp; Exchange Commission, which is available at this hyperlink. Also, insider Brian C. Evanko sold 5,368 shares of the stock in a transaction that occurred on Friday, October 3rd. The stock was sold at an average price of $300.00, for a total value of $1,610,400.00. Following the completion of the transaction, the insider owned 51,182 shares of the company's stock, valued at $15,354,600. The trade was a 9.49% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. 0.70% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在相关消息中，首席执行官 David Cordani 于 11 月 3 日购买了 4,134 股信诺保险集团股票，交易总额为 999,931.92 美元，平均每股价格为 241.88 美元。收购后，首席执行官直接持有该公司 157,935 股股票，价值约 38,201,317.80 美元。此次交易使其持股比例增加了 2.69%。该购买在美国证券交易委员会的备案中披露，相关文件可通过此链接获取。此外，内部人士 Brian C. Evanko 于 10 月 3 日出售了 5,368 股该股票，交易总额为 1,610,400.00 美元，平均每股价格为 300.00 美元。交易完成后，内部人士持有该公司 51,182 股股票，价值 15,354,600 美元。此次出售的披露信息可在美国证券交易委员会的备案中找到。目前，公司的内部人士持有 0.70% 的股票。</p>
</div><h2>Cigna Group Price Performance</h2>
<div class="lb-trans"><h2>信诺保险集团价格表现</h2>
</div><ul>
<li>MarketBeat Week in Review – 01/06 - 01/10</li>
</ul>
<div class="lb-trans"><ul>
<li>MarketBeat 周回顾 – 01/06 - 01/10</li>
</ul>
</div><p>Shares of CI stock opened at $274.70 on Friday. The company has a current ratio of 0.76, a quick ratio of 0.76 and a debt-to-equity ratio of 0.74. The stock has a market capitalization of $73.38 billion, a price-to-earnings ratio of 12.12, a P/E/G ratio of 0.99 and a beta of 0.26. The stock has a fifty day simple moving average of $280.44 and a two-hundred day simple moving average of $294.17. Cigna Group has a twelve month low of $239.51 and a twelve month high of $350.00.</p>
<div class="lb-trans"><p>CI 股票在周五开盘价为 274.70 美元。该公司的流动比率为 0.76，速动比率为 0.76，债务与股本比率为 0.74。该股票的市值为 733.8 亿美元，市盈率为 12.12，市盈增长比率为 0.99，贝塔值为 0.26。该股票的 50 日简单移动平均线为 280.44 美元，200 日简单移动平均线为 294.17 美元。信诺保险集团的 12 个月低点为 239.51 美元，12 个月高点为 350.00 美元。</p>
</div><p>Cigna Group (NYSE:CI - Get Free Report) last announced its earnings results on Thursday, October 30th. The health services provider reported $7.83 earnings per share (EPS) for the quarter, beating the consensus estimate of $7.64 by $0.19. Cigna Group had a return on equity of 18.80% and a net margin of 2.29%.The company had revenue of $69.57 billion for the quarter, compared to analyst estimates of $66.40 billion. During the same period in the prior year, the company posted $7.51 EPS. The firm's quarterly revenue was up 9.5% compared to the same quarter last year. Cigna Group has set its FY 2025 guidance at 29.600- EPS. On average, analysts predict that Cigna Group will post 29.77 EPS for the current fiscal year.</p>
<div class="lb-trans"><p>信诺保险集团（NYSE:CI - 获取免费报告）最近于 10 月 30 日公布了其财报。该健康服务提供商报告的每股收益（EPS）为 7.83 美元，超出市场共识预期的 7.64 美元，超出幅度为 0.19 美元。信诺保险集团的股本回报率为 18.80%，净利润率为 2.29%。该公司在本季度的收入为 695.7 亿美元，而分析师预期为 664.0 亿美元。在去年同期，该公司每股收益为 7.51 美元。该公司的季度收入较去年同期增长了 9.5%。信诺保险集团已将其 2025 财年的指导目标设定为 29.600- 每股收益。分析师平均预测信诺保险集团本财年将发布 29.77 美元的每股收益。</p>
</div><h2>Cigna Group Announces Dividend</h2>
<div class="lb-trans"><h2>信诺保险集团宣布分红</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, December 18th. Investors of record on Thursday, December 4th will be paid a dividend of $1.51 per share. This represents a $6.04 annualized dividend and a yield of 2.2%. The ex-dividend date of this dividend is Thursday, December 4th. Cigna Group's dividend payout ratio is currently 26.64%.</p>
<div class="lb-trans"><p>该公司最近还披露了季度分红，将于 12 月 18 日支付。12 月 4 日的登记投资者将获得每股 1.51 美元的分红。这相当于每年 6.04 美元的分红，收益率为 2.2%。该分红的除息日为 12 月 4 日。信诺保险集团的分红支付比率目前为 26.64%。</p>
</div><h2>Cigna Group Profile</h2>
<div class="lb-trans"><h2>信诺保险集团简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>The Cigna Group, together with its subsidiaries, provides insurance and related products and services in the United States. Its Evernorth Health Services segment provides a range of coordinated and point solution health services, including pharmacy benefits, home delivery pharmacy, specialty pharmacy, distribution, and care delivery and management solutions to health plans, employers, government organizations, and health care providers.</p>
<div class="lb-trans"><p>信诺保险集团及其子公司在美国提供保险及相关产品和服务。其 Evernorth 健康服务部门提供一系列协调和定点解决方案的健康服务，包括药品福利、家庭送药、特殊药房、分销以及向健康计划、雇主、政府组织和医疗服务提供者提供的护理交付和管理解决方案。</p>
</div><h2>Featured Stories</h2>
<div class="lb-trans"><h2>精选故事</h2>
</div><ul>
<li>Five stocks we like better than Cigna Group</li>
<li>How to Find Undervalued Stocks</li>
<li>Synopsys Sees Bullish Shift as Ansys Integration Drives Growth</li>
<li>Health Care Stocks Explained: Why You Might Want to Invest</li>
<li>The Best Holiday Present You Can Give Yourself? Costco Stock</li>
<li>What is the Dow Jones Industrial Average (DJIA)?</li>
<li>Why Zscaler Stock Could Be Ready to Bounce After a 30% Selloff</li>
</ul>
<div class="lb-trans"><ul>
<li>我们更看好的五只股票超过信诺保险</li>
<li>如何寻找被低估的股票</li>
<li>Synopsys 看到乐观转变，因为 Ansys 整合推动增长</li>
<li>医疗保健股票解析：为什么你可能想要投资</li>
<li>你能给自己最好的节日礼物是什么？好市多股票</li>
<li>道琼斯工业平均指数（DJIA）是什么？</li>
<li>为什么 Zscaler 股票在经历 30% 的抛售后可能准备反弹</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding CI?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Cigna Group (NYSE:CI - Free Report).</p>
<div class="lb-trans"><p><strong>想看看其他对 CI 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取信诺保险（NYSE:CI - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPUNJ" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=CI"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙事科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快的报道和公正的覆盖。请将任何问题或意见发送至 contact@marketbeat.com.</em></p>
</div><h2>Should You Invest $1,000 in Cigna Group Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1,000 美元在信诺保险吗？</h2>
</div><p>Before you consider Cigna Group, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑信诺保险之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cigna Group wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前购买……而信诺保险并不在名单上。</p>
</div><p>While Cigna Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然信诺保险目前在分析师中有中等买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>在这里查看这五只股票</p>
</div>

Balyasny 资产管理公司购买了 369,775 股信诺保险集团（Cigna Group）的股票$CI